PMID: 9917439

Wilschanski M, Rivlin J, Cohen S, Augarten A, Blau H, Aviram M, Bentur L, Springer C, Vila Y, Branski D, Kerem B, Kerem E
Clinical and genetic risk factors for cystic fibrosis-related liver disease.
Pediatrics. 1999 Jan;103(1):52-7., [PubMed]
Sentences
No. Mutations Sentence Comment
32 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 9917439:32:189
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 9917439:32:169
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 9917439:32:137
status: NEW
view ABCC7 p.Arg553* details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 9917439:32:177
status: NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 9917439:32:162
status: NEW
view ABCC7 p.Gly542* details
The correlation between liver disease and CF genotype was studied in seven mutations associated with the severe phenotype: ⌬F508, R553X, 1717-1G-ϾA, G542X, W1282X, N1303K, and G551D.2,14 No significant cor- From the *Department of Pediatrics, Cystic Fibrosis Center, Shaare Zedek Medical Center, Hebrew University, Jerusalem; ‡Cystic Fibrosis Center, Carmel Medical Center, Haifa; §Cystic Fibrosis Center, Sheba Medical Center, Tel Hashomer; ࿣Cystic Fibrosis Center, Schneider Children`s Medical Center, Petah Tikva; ¶Cystic Fibrosis Center, Soroka Medical Center, Ben Gurion University, Beer Sheba; #Cystic Fibrosis Center, Rambam Medical Center, Haifa; **Cystic Fibrosis Center, Hadassah University Hospital, Jerusalem; ‡‡Department of Medical Statistics, Ichilov Medical Center, Tel Aviv; and §§Department of Genetics, Life Sciences Institute, Hebrew University, Jerusalem, Israel. Login to comment
50 ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 9917439:50:578
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 9917439:50:593
status: NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 9917439:50:586
status: NEW
view ABCC7 p.Gly542* details
Forced expiratory volume in 1 second, and forced vital capacity, were measured and expressed as a percentage of predicted values for height and sex, using previously described standardized pulmonary equations.17 Current height and weight percentiles were computed using the tables of Tanner.18 Mutation Analysis All the patients were screened for all of the CFTR mutations previously identified in the Israeli CF population.15,16 Patients were classified according to severity of genotype: patients with severe genotype were homozygous or compound heterozygous to ⌬F508, W1282X, G542X, N1303K, 405ϩ1G3A, delTATT 4010, 1717-1G-ϾA. Login to comment
51 ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9917439:51:484
status: NEW
view ABCC7 p.Gly85Glu details
These mutations were shown to be associated with PI, early age at diagnosis, higher sweat chloride level, and lower current age.3,4 Patients with the milder genotype carried the mutation 3849ϩ10kb C-ϾT, which was shown to be associated with increased incidence of PS, later age at diagnosis, higher current age, normal or intermediate range sweat chloride levels, and male fertility.19,20 Patients with a variable genotype were homozygous or compound heterozygous for the G85E mutation, or compound heterozygous for the 5T allele that may present with either severe or milder phenotype.6,7 Unclassified genotypes were mutations which, because of the small number of patients, have not been sufficiently characterized. Login to comment
114 ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9917439:114:50
status: NEW
view ABCC7 p.Gly85Glu details
However, patients carrying the variable genotype (G85E or 5T,6,7 ), which is also associated with high rate of PS, had a Fig 1. Login to comment
117 ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 9917439:117:216
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 9917439:117:223
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 9917439:117:314
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 9917439:117:348
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 9917439:117:373
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 9917439:117:474
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 9917439:117:490
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 9917439:117:518
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 9917439:117:534
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 9917439:117:525
status: NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 9917439:117:293
status: NEW
view ABCC7 p.Gly542* details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 9917439:117:395
status: NEW
view ABCC7 p.Gly542* details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 9917439:117:481
status: NEW
view ABCC7 p.Gly542* details
ABCC7 p.Ser549Arg
X
ABCC7 p.Ser549Arg 9917439:117:202
status: NEW
view ABCC7 p.Ser549Arg details
ABCC7 p.Ser549Arg
X
ABCC7 p.Ser549Arg 9917439:117:208
status: NEW
view ABCC7 p.Ser549Arg details
ABCC7 p.Ser549Arg
X
ABCC7 p.Ser549Arg 9917439:117:287
status: NEW
view ABCC7 p.Ser549Arg details
ABCC7 p.Ser549Arg
X
ABCC7 p.Ser549Arg 9917439:117:367
status: NEW
view ABCC7 p.Ser549Arg details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9917439:117:195
status: NEW
view ABCC7 p.Gly85Glu details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9917439:117:275
status: NEW
view ABCC7 p.Gly85Glu details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9917439:117:280
status: NEW
view ABCC7 p.Gly85Glu details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9917439:117:357
status: NEW
view ABCC7 p.Gly85Glu details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9917439:117:427
status: NEW
view ABCC7 p.Gly85Glu details
ABCC7 p.Tyr1092*
X
ABCC7 p.Tyr1092* 9917439:117:502
status: NEW
view ABCC7 p.Tyr1092* details
ABCC7 p.Tyr1092*
X
ABCC7 p.Tyr1092* 9917439:117:509
status: NEW
view ABCC7 p.Tyr1092* details
ABCC7 p.Trp1089*
X
ABCC7 p.Trp1089* 9917439:117:465
status: NEW
view ABCC7 p.Trp1089* details
ABCC7 p.Thr360Lys
X
ABCC7 p.Thr360Lys 9917439:117:552
status: NEW
view ABCC7 p.Thr360Lys details
ABCC7 p.Gln359Lys
X
ABCC7 p.Gln359Lys 9917439:117:546
status: NEW
view ABCC7 p.Gln359Lys details
Classification of Identified Genotype According to Severity of Disease Severe n Milder n Variable n Unclassified n ⌬F508/⌬F508 52 3849 ϩ 10kbC 3 T/⌬F508 7 ⌬F508/G85E 1 S549R/S549R 1 W1282X/W1282X 30 3849 ϩ 10kbC 3 T/405 ϩ 1G3A 3 G85E/G85E 5 S549R/G542X 2 ⌬F508/W1282X 39 3849 ϩ 10 kbC 3 T/W1282X 7 G85E/5T 1 S549R/W1282X 1 ⌬F508/G542X 10 3849 ϩ 10kbC 3 T/G85E 1 ⌬F508/5T 1 ⌬F508/W1089X 1 W1282X/G542X 12 W1282X/5T 2 Y1092X/Y1092X 1 W1282X/N1303K 7 W1282X/5T 1 Q359K-T360K/? Login to comment
118 ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 9917439:118:2
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Trp1089*
X
ABCC7 p.Trp1089* 9917439:118:31
status: NEW
view ABCC7 p.Trp1089* details
2 W1282X/405 ϩ 1G3A 1 5T/W1089X 2 ⌬F508/? Login to comment
120 ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 9917439:120:2
status: NEW
view ABCC7 p.Trp1282* details
3 W1282X/? Login to comment
121 ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 9917439:121:3
status: NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 9917439:121:18
status: NEW
view ABCC7 p.Gly542* details
12 N1303K/T4010 2 G542X/? Login to comment
122 ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 9917439:122:2
status: NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 9917439:122:9
status: NEW
view ABCC7 p.Gly542* details
3 N1303K/G542X 3 405 ϩ 1G3A/? Login to comment
123 ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 9917439:123:77
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 9917439:123:2
status: NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 9917439:123:9
status: NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 9917439:123:112
status: NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 9917439:123:98
status: NEW
view ABCC7 p.Gly542* details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 9917439:123:104
status: NEW
view ABCC7 p.Gly542* details
ABCC7 p.Thr360Lys
X
ABCC7 p.Thr360Lys 9917439:123:24
status: NEW
view ABCC7 p.Thr360Lys details
ABCC7 p.Thr360Lys
X
ABCC7 p.Thr360Lys 9917439:123:39
status: NEW
view ABCC7 p.Thr360Lys details
ABCC7 p.Gln359Lys
X
ABCC7 p.Gln359Lys 9917439:123:18
status: NEW
view ABCC7 p.Gln359Lys details
ABCC7 p.Gln359Lys
X
ABCC7 p.Gln359Lys 9917439:123:33
status: NEW
view ABCC7 p.Gln359Lys details
1 N1303K/N1303K 6 Q359K-T360K/ 4 Q359K-T360K ⌬F508/405 ϩ 1G3A 5 W1282X/1717-1G 3 A 1 G542X/G542X 1 N1303K/1717-1G 3 A 1 Total 173 18 16 36 ARTICLES high prevalence of liver disease. Login to comment
129 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 9917439:129:291
status: NEW
view ABCC7 p.Arg117His details
The coexistence of two independent DNA alterations in the same CFTR allele might modulate the phenotype.30 Variations in intronic signals for splicing of CFTR transcripts, such as the 5T allele in intron 8 of the CFTR gene, were shown to affect the disease severity of patients carrying the R117H mutation.31 However, in our study no other CFTR mutation was found in the same CFTR alleles of the 3849ϩ10kb C-ϾT mutation that were in all the patients associated with the 7T variant. Login to comment
132 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 9917439:132:127
status: NEW
view ABCC7 p.Arg117His details
Therefore, the extrapolation of our results onto other populations who have a higher incidence of other mild mutations such as R117H requires further studies. Login to comment